About: TRC-150094

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org:8891

TRC-150094 is a drug which acts as a metabolic modulator which restores metabolic flexibility. It has been shown to improve insulin resistance and hyperglycemia, and is in Phase III human clinical trials for the treatment of Cardiometabolic-Based Chronic Disease (CMBCD) by improving dysglycemia, dyslipidemia and hypertension.

Property	Value
dbo:abstract	TRC-150094 is a drug which acts as a metabolic modulator which restores metabolic flexibility. It has been shown to improve insulin resistance and hyperglycemia, and is in Phase III human clinical trials for the treatment of Cardiometabolic-Based Chronic Disease (CMBCD) by improving dysglycemia, dyslipidemia and hypertension. (en)
dbo:casNumber	1092551-88-6
dbo:chEMBL	4297445
dbo:fdaUniiCode	B93608MTGW
dbo:pubchem	25125529
dbo:thumbnail	wiki-commons:Special:FilePath/TRC-150094_structure.png?width=300
dbo:wikiPageID	66200541 (xsd:integer)
dbo:wikiPageLength	3412 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1060779206 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Metabolic_flexibility dbr:Dysglycemia dbr:Insulin_resistance dbr:Clinical_trial dbc:Drugs dbc:Hormones dbc:Thyroid dbr:Hyperglycemia
dbp:c	19 (xsd:integer)
dbp:casNumber	1092551 (xsd:integer)
dbp:chembl	4297445 (xsd:integer)
dbp:chemspiderid	28534873 (xsd:integer)
dbp:h	24 (xsd:integer)
dbp:iupacName	3 (xsd:integer)
dbp:n	2 (xsd:integer)
dbp:o	3 (xsd:integer)
dbp:pubchem	25125529 (xsd:integer)
dbp:smiles	CC1=CCCC3=CC (en)
dbp:stdinchi	1 (xsd:integer)
dbp:stdinchikey	OFUOCIUIWKDKPA-UHFFFAOYSA-N (en)
dbp:unii	B93608MTGW (en)
dbp:wikiPageUsesTemplate	dbt:Drugbox dbt:Pharm-stub dbt:Reflist
dcterms:subject	dbc:Drugs dbc:Hormones dbc:Thyroid
rdf:type	owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 dbo:Drug
rdfs:comment	TRC-150094 is a drug which acts as a metabolic modulator which restores metabolic flexibility. It has been shown to improve insulin resistance and hyperglycemia, and is in Phase III human clinical trials for the treatment of Cardiometabolic-Based Chronic Disease (CMBCD) by improving dysglycemia, dyslipidemia and hypertension. (en)
rdfs:label	TRC-150094 (en)
owl:sameAs	wikidata:TRC-150094 https://global.dbpedia.org/id/2bXhU dbr:TRC-150094
prov:wasDerivedFrom	wikipedia-en:TRC-150094?oldid=1060779206&ns=0
foaf:depiction	wiki-commons:Special:FilePath/TRC-150094_structure.png
foaf:isPrimaryTopicOf	wikipedia-en:TRC-150094
is dbo:wikiPageWikiLink of	dbr:Triiodothyronine
is foaf:primaryTopic of	wikipedia-en:TRC-150094